News summary
[The State Food and Drug Administration approves the listing of ivocizumab injection] Securities Times e Company News, recently, the State Food and Drug Administration approved the application of Kangfonsano Pharmaceutical Co., Ltd. through the priority review and approval processwaterlandarcadeivocizumab injection (trade namewaterlandarcade: Idafang) is listed. This product is combined with pemetrexed andwaterlandarcade.waterlandarcade..
Newsletter text
[The State Food and Drug Administration approves the listing of Ivolumab injection] Securities Times e Company News that recently, the State Food and Drug Administration approved the listing of Ivolumab injection (trade name: Idarfang) applied by Kangfangsano Pharmaceutical Co., Ltd. through the priority review and approval process. This product is used in combination with pemetrexed and carboplatin for the treatment of patients with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) who have progressed after epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) treatment.